NCT Number: NCT00899691
Study of Hair Samples From Patients With Cancer
RATIONALE: Studying samples of hair in the laboratory from patients with cancer may help doctors identify biomarkers related to cancer and predict how well patients will respond to treatment.
PURPOSE: This laboratory study is looking at hair samples from patients with cancer.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- Determine whether layered membrane technology can quantitatively measure the expression, activity, and localization of cell growth control and signaling proteins in hair samples from patients with cancer.
- Correlate changes in protein expression with expected changes based on planned therapy in these patients.
OUTLINE: This is a pilot, multicenter study.
Hair samples are obtained from patients at baseline and at the end of study. The samples are assayed for proteins and phosphorylation status using layered membrane technology. Proteins analyzed may include vascular endothelial growth factor receptor (VEGFR), Erk1/2, Akt, epidermal growth factor receptor (EGFR), and c-KIT.
PROJECTED ACCRUAL: A total of 190 patients will be accrued for this study within 3 years.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of malignancy
- Undergoing treatment at the National Cancer Institute's Clinical Center
- Must have scalp hair
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Treatment and study plan
Primary outcomes
-
Obtain data on the detection and quantification of changes in levels of protein expression and phosphorylation status using human hair samples at baseline and after completion of study
Sponsors and collaborators
Lead sponsor
National Institutes of Health Clinical Center (CC)
Nih
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Detection and Quantification of Changes in Levels of Protein Expression and Phosphorylation Status Using Human Hair Samples
Important dates
- Study start
- 2005
- Study completion
- 2008
- First posted
- May 12, 2009
- Registry last updated
- Mar 15, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
NCT02088775
Adenocarcinoma, Adult Primary Hepatocellular Carcinoma
Philadelphia, Pennsylvania, United States
View Trial DetailsHypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis
NCT01705548
Brain Diseases, Brain Neoplasms
Atlanta, Georgia, United States
View Trial DetailsAPF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
NCT00343460
Nausea, Nausea and Vomiting
Anniston, Alabama, United States
View Trial DetailsMorphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
NCT00712712
Metastatic Cancer, Neoplasm Metastasis
Bordeaux, France
View Trial Details